Cargando…
Glucagon-like peptide-1 receptor blockade impairs islet secretion and glucose metabolism in humans
BACKGROUND: Proglucagon can be processed to glucagon-like peptide1 (GLP-1) within the islet, but its contribution to islet function in humans remains unknown. We sought to understand whether pancreatic GLP-1 alters islet function in humans and whether this is affected by type 2 diabetes. METHODS: We...
Autores principales: | Welch, Andrew A., Farahani, Rahele A., Egan, Aoife M., Laurenti, Marcello C., Zeini, Maya, Vella, Max, Bailey, Kent R., Cobelli, Claudio, Dalla Man, Chiara, Matveyenko, Aleksey, Vella, Adrian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645389/ https://www.ncbi.nlm.nih.gov/pubmed/37751301 http://dx.doi.org/10.1172/JCI173495 |
Ejemplares similares
-
The relationship between insulin and glucagon concentrations in non‐diabetic humans
por: Laurenti, Marcello C., et al.
Publicado: (2022) -
Measurement of Pulsatile Insulin Secretion: Rationale and Methodology
por: Laurenti, Marcello C., et al.
Publicado: (2021) -
Nonlinear Mixed Effects Modeling of Glucagon Kinetics in Healthy Subjects
por: Faggionato, Edoardo, et al.
Publicado: (2023) -
Defective Glucagon-Like Peptide 1 Secretion in Prediabetes and Type 2 Diabetes Is Influenced by Weight and Sex. Chicken, Egg, or None of the Above?
por: Vella, Adrian, et al.
Publicado: (2015) -
Regenerative Medicine in Diabetes
por: Matveyenko, Aleksey, et al.
Publicado: (2015)